1. Home
  2. CRML vs INMB Comparison

CRML vs INMB Comparison

Compare CRML & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRML
  • INMB
  • Stock Information
  • Founded
  • CRML N/A
  • INMB 2015
  • Country
  • CRML United States
  • INMB United States
  • Employees
  • CRML N/A
  • INMB N/A
  • Industry
  • CRML
  • INMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRML
  • INMB Health Care
  • Exchange
  • CRML NYSE
  • INMB Nasdaq
  • Market Cap
  • CRML 177.5M
  • INMB 176.5M
  • IPO Year
  • CRML N/A
  • INMB 2019
  • Fundamental
  • Price
  • CRML $1.42
  • INMB $7.19
  • Analyst Decision
  • CRML
  • INMB Strong Buy
  • Analyst Count
  • CRML 0
  • INMB 3
  • Target Price
  • CRML N/A
  • INMB $24.33
  • AVG Volume (30 Days)
  • CRML 2.1M
  • INMB 274.4K
  • Earning Date
  • CRML 02-01-2025
  • INMB 05-08-2025
  • Dividend Yield
  • CRML N/A
  • INMB N/A
  • EPS Growth
  • CRML N/A
  • INMB N/A
  • EPS
  • CRML N/A
  • INMB N/A
  • Revenue
  • CRML $476,979.00
  • INMB $50,000.00
  • Revenue This Year
  • CRML N/A
  • INMB N/A
  • Revenue Next Year
  • CRML N/A
  • INMB $43,178.43
  • P/E Ratio
  • CRML N/A
  • INMB N/A
  • Revenue Growth
  • CRML 326.80
  • INMB N/A
  • 52 Week Low
  • CRML $1.23
  • INMB $4.32
  • 52 Week High
  • CRML $12.00
  • INMB $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CRML 43.59
  • INMB 44.62
  • Support Level
  • CRML $1.33
  • INMB $7.25
  • Resistance Level
  • CRML $1.64
  • INMB $8.06
  • Average True Range (ATR)
  • CRML 0.13
  • INMB 0.47
  • MACD
  • CRML 0.01
  • INMB -0.02
  • Stochastic Oscillator
  • CRML 36.96
  • INMB 3.81

About CRML CRITICAL METALS CORPORATION

Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: